Iterum Therapeutics (ITRM)
NASDAQ: ITRM
· Real-Time Price · USD
0.83
-0.04 (-4.60%)
At close: Aug 19, 2025, 3:59 PM
0.86
3.58%
Pre-market: Aug 20, 2025, 04:06 AM EDT
Iterum Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.51M | -4.89M | -6.58M | -6.09M | -5M | -7.1M | -12.36M | -3.88M | -12.24M | -9.89M | -5.09M | -29.11M | -6.74M | -3.5M | -4.18M | 3.74M | 7.8M | -98.92M |
Depreciation & Amortization | 351K | 349K | 261K | 8K | 8K | 7K | 440K | 436K | 438K | 436K | 439K | 448K | 455K | 458K | 1.77M | 111K | 185K | 35K |
Stock-Based Compensation | 56K | 61K | 89K | 68K | 68K | 138K | 139K | 142K | 110K | 393K | 457K | 422K | 1.98M | 1.9M | 1.97M | 1.51M | 559K | 281K |
Other Working Capital | -549.48K | 106K | -836K | -70.31K | -1.31M | -5.73M | -1.8M | 4.14M | 362K | -2.18M | 809K | -253K | -1.38M | 1.24M | -796K | -618K | -2.3M | 3.21M |
Other Non-Cash Items | 1.29M | 1.69M | 3.4M | 3.42M | 1.68M | 3.81M | 3.24M | 1.3M | 1.26M | 2.19M | -2.42M | 23.51M | -687K | -3.31M | 1.46M | 2.64M | 977K | 3.07M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.57M | -13.2M | 960K | n/a | n/a | n/a | n/a | n/a | -3.28M | -9.63M | -15.65M | 90.16M |
Change in Working Capital | -187.86K | -266K | -1.42M | -73K | -3.44M | -7.76M | -2.34M | 5.93M | 1.84M | -2.72M | 2.35M | 190K | -1.28M | 1.05M | -193K | -2.29M | -2.21M | 4.25M |
Operating Cash Flow | -5.05M | -3.06M | -4.26M | -2.67M | -6.68M | -13.08M | -12.46M | -9.27M | -7.63M | -9.59M | -4.26M | -4.54M | -6.26M | -3.4M | -2.46M | -3.91M | -8.34M | -1.13M |
Capital Expenditures | -73.32 | -2K | -7.99 | n/a | -1.99K | n/a | 155.93 | 3K | -16.11K | n/a | -45K | -7K | -10K | n/a | -13K | -48K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -15.76K | -357 | 16.11K | n/a | -4.42K | -15.85K | 15.85K | n/a | 9.95M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -5.85M | -6.49M | -4.72M | -9.14M | -22.97M | -3.89M | -9.68M | -1.17M | -23.55M | -11.31M | -6.95M | -5.02M | -21.14M | -33.92M |
Sales Maturities Of Investments | n/a | n/a | 1.1M | 5.7M | 10M | 13.7M | 18.05M | 9.5M | 27.33M | 9M | 14.1M | 17.03M | 7.7M | 20.9M | 2.5M | 9.84M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 0.01 | 7.21M | -0.93 | 357.00 | -16K | 5.11K | 4.42K | 15.85K | -15.85K | 9.59M | -9.95M | 10M | -21.14M | -33.92M |
Investing Cash Flow | -77.17 | -2K | 1.1M | 5.7M | 4.15M | 7.21M | 13.33M | 360K | 4.35M | 5.11M | 4.38M | 15.85M | -15.86M | 9.59M | -4.47M | 4.93M | -21.14M | -33.92M |
Debt Repayment | -568.93K | -14.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 72.3K | 57.77K | -2.25M | -1.49M | -1.55M | -1.63M | -1.63M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -8.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -136.14K | -80.2K | n/a | n/a |
Financial Cash Flow | 4.99M | -8.39M | 13.88M | 5.43M | 137.49K | 7.22M | 580.56K | 10K | 200K | 235K | 433K | 72.3K | 57.77K | -2.25M | -1.63M | -1.63M | -592K | 86.98M |
Net Cash Flow | 374K | -11.47M | 10.72M | 8.43M | -2.41M | 1.32M | 1.25M | -8.92M | -3.1M | -4.26M | 573K | 11.28M | -22.15M | 3.92M | -8.54M | -621K | -30.07M | 51.92M |
Free Cash Flow | -5.05M | -3.06M | -4.26M | -2.67M | -6.76M | -13.08M | -12.46M | -9.26M | -7.65M | -9.59M | -4.31M | -4.55M | -6.27M | -3.4M | -2.47M | -3.96M | -8.34M | -1.13M |